Stacy Macpherson, Clinical Application Scientist at CooperSurgical discusses how cryoprotectants play a significant role in the vitrification process and how embryologists can add to their knowledge base to help support clinical practice and continue to develop successful vitrification protocols.
Learn how research on PGT-Complete, shows a high rate of accuracy in genetic parentage confirmation of an embryo, which can give patients more confidence in the PGT result.
Naval Shah, Head of Quality Assurance and Training Indira IVF, India discusses how the RI Witness IQ™ solution with its intelligent data collection and analysis into their laboratory management has given them a better overview across their clinic group for enhanced clinic proficiency.
Johan Sterckx, Lab Quality Manager of Brussels IVF in Belgium, discusses the challenges that face a large fertility clinic who accumulate a lot of data and how RI Witness IQ can support a large data output and provide meaningful analysis and insights for more advanced fact-based laboratory management.
Alpesh Doshi, Lab Director and Co-Founder of IVF London, UK, discusses how fertility clinics today have adopted cryopreservation and vitrification as a key strategy for patients and how flexibility in vitrification products can help clinics ensure better cost awareness and optimize lab efficiency.
Dr. Nagy, Scientific & Laboratory Director and Embryologist Dr. Chang, both from Reproductive Biology Associates (RBA), discuss how vitrification has empowered patients with more fertility treatment options and how flexibility in vitrification protocols is essential to ensure reliable and consistent clinical outcomes in IVF labs.
Dr. Barrie, CARE Fertility Laboratory Manager and Dr. Tucker, Shady Grove Fertility Scientific Director, discuss how digital and automated integration can support clinics and patients throughout the entire fertility journey and play a role in improving lab performance.
Rob Thompson and Peter Bacher from CooperSurgical discuss the comprehensive role digital and automated integration can play in the standardization of clinics and how intelligent data collection can provide the metrics that may improve fertility outcomes.
Tony Gordon, Vice President of Business Development, discusses how the data collected in the fertility care industry, if put to use and analyzed, can provide clinics and patients with crucial evidence that can enable them to make better informed decisions.
Dr. Marcos Meseguer, Scientific Supervisor and Senior Embryologist, talks about the challenges IVF clinics face when trying to adopt a 'gold standard' and why the fertility industry involvement is a great first step in supporting clinics in changing the standards of fertility care.
Holly Sheffield, President of CooperSurgical discusses today’s challenges in the fertility care industry and their focus on – Changing fertility care for generations to come.
Caitie Witherspoon, IVF patient, talks about the many challenges in their fertility journey and her belief that the availability of innovative technology can help patients find a personalized fertility treatment that’s right for them.
Dr. Shipra Thukral, Marketing Director,CooperSurgical India explores how working together in changing the standards in fertility care can raise the quality and consistency of treatment for patients and help optimize fertility outcomes in clinics.
Rachel Chin, Clinical Application Manager, discusses her belief that standardized workflows in clinics can help raise the standards of treatment for patients and optimize fertility outcomes.
Professor Christopher Barratt, an active member in the World Health Organization, talks about his work in male infertility, the importance of education and why WHO has decided to play a key role in creating standards of fertility care.
Inge Errebo Agerholm, Senior Director Medical Affairs International, discusses her team’s role in helping clinics utilize data to troubleshoot and improve laboratory practices and how a future focused on data utilization for education & training is essential in changing the standards of fertility care.
My Clinic is in the United States
My Clinic is in Canada